Novel 1,3,4-Oxadiazole Induces Anticancer Activity by Targeting NF-κB in Hepatocellular Carcinoma Cells

Aberrant activation of NF-κB is linked with the progression of human malignancies including hepatocellular carcinoma (HCC), and blockade of NF-κB signaling could be a potential target in the treatment of several cancers. Therefore, designing of novel small molecule inhibitors that target NF-κB activ...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Front Oncol
Asıl Yazarlar: Mohan, Chakrabhavi Dhananjaya, Anilkumar, Nirvanappa C., Rangappa, Shobith, Shanmugam, Muthu K., Mishra, Srishti, Chinnathambi, Arunachalam, Alharbi, Sulaiman Ali, Bhattacharjee, Atanu, Sethi, Gautam, Kumar, Alan Prem, Basappa, Rangappa, Kanchugarakoppal S.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Frontiers Media S.A. 2018
Konular:
Oncology
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5867297/
https://ncbi.nlm.nih.gov/pubmed/29616186
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2018.00042
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller